Recent Updates
Recently added Catalysts
VNDA

Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders ROCKVILLE, MD., March 10/PRNewswire-FirstCall/ Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that it will hold its 2010 Annu

Key Takeaway: Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders ROCKVILLE, MD., March 10/PRNewswire-FirstCall/ Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) announced today that it will hold its 2010 Annual Meeting of Stockholders on Thursday, June 3, 2010, in Rockville, Ma

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+121%
120-day peak, hindsight
Typical move
19.9%
average across 7 past catalysts
Cash runway
~16 mo
Low dilution risk
Lead asset
Imsidolimab
Phase 2 · Palmoplantar Pustulosis

Full Press Release Details

Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
ROCKVILLE, MD., March 10/PRNewswire-FirstCall/ Vanda Pharmaceuticals Inc. (Nasdaq: VNDA)
announced today that it will hold its 2010 Annual Meeting of Stockholders on Thursday, June 3,
2010, in Rockville, Maryland. The record date for the Annual Meeting will be April 16, 2010. Only
stockholders of record at the close of business on April 16, 2010 may vote at the meeting or any
adjournment thereof. Vanda anticipates mailing its proxy statement in April 2010 to its
stockholders of record, which proxy statement will include the time and location of the Annual
Meeting, as well as a description of the matters to be considered.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and
commercialization of clinical-stage products for central nervous system disorders. For more on
Vanda, please visit http://www.vandapharma.com.
Investor and Media Contact:
Last updated: Mar 10, 2010